Genmab A/S (GMAB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
44.04-0.22 (-0.50%)
At close: 4:00PM EDT
| Previous close | 44.26 |
| Open | 44.27 |
| Bid | 43.00 x 1000 |
| Ask | 45.07 x 1400 |
| Day's range | 43.93 - 44.56 |
| 52-week range | 30.10 - 49.07 |
| Volume | 225,916 |
| Avg. volume | 365,728 |
| Market cap | 28.776B |
| Beta (5Y monthly) | 0.59 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
Genmab A/S (GMAB) Q2 2021 Earnings Call Transcript
Genmab is not under any obligation to update statements regarding the future, nor to confirm such statements in relation to actual results, unless this is required by law. Please also note that Genmab may hold your personal data as indicated by you as part of our Investor Relations outreach activities in order to update you on Genmab going forward. Hello, and welcome to the Genmab conference call to discuss the Company's financial results for the first half of 2021.
- Zacks
Is a Surprise Coming for Genmab (GMAB) This Earnings Season?
Genmab (GMAB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- Zacks
ALXN or GMAB: Which Is the Better Value Stock Right Now?
ALXN vs. GMAB: Which Stock Is the Better Value Option?
© 2021 Verizon Media. All rights reserved.
